Append MedicalAppend Medical
Append Medical

Append Medical

Develops a novel device for complete left atrial appendage closure to prevent blood clots and strokes.

2016Active30

About

Append Medical is developing a novel transcatheter system for Left Atrial Appendage (LAA) elimination without implanting any device in the heart. This innovative approach aims to reduce stroke risks for patients with Non-Valvular Atrial Fibrillation (NVAF) by eradicating risks associated with Device Related Thromboembolism (DRT) and Peri Device Leakage (PDL). The system is designed to fit a wide range of anatomies and offers a fast, implant-free solution.

Technology stack

detected 2026-06-17
Est. monthly stack spend~$340/mo
EmailMicrosoft 365
Hosting
self_managed
Stack
jQueryWordPress
SEO
Yoast SEO
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Append Medical do?

Append Medical is developing a novel transcatheter system for Left Atrial Appendage (LAA) elimination without implanting any device in the heart. This innovative approach aims to reduce stroke risks for patients with Non-Valvular Atrial Fibrillation (NVAF) by eradicating risks associated with Device Related Thromboembolism (DRT) and Peri Device Leakage (PDL). The system is designed to fit a wide range of anatomies and offers a fast, implant-free solution.

How much funding has Append Medical raised?

Append Medical has raised a total of $12M in funding. The most recent round on record is Series A.

Where is Append Medical headquartered?

Append Medical is headquartered in San Francisco, United States.

When was Append Medical founded?

Append Medical was founded in 2016.

What industry does Append Medical operate in?

Append Medical operates in Healthcare, Medical Device, MedTech, HealthTech, Cardiovascular, Thrombosis Prevention.

How many employees does Append Medical have?

Append Medical has approximately 30 people on record.